The Impact of Cancer-Associated Fibroblasts on Drug Resistance, Stemness, and Epithelial-Mesenchymal Transition in Bladder Cancer: A Comparison between Recurrent and Non-Recurrent Patient-Derived CAFs

被引:11
|
作者
Rastegar-Pouyani, Nima [1 ]
Montazeri, Vahideh [2 ]
Marandi, Nikoo [3 ]
Aliebrahimi, Shima [2 ]
Andalib, Melika [4 ]
Jafarzadeh, Emad [1 ]
Montazeri, Hamed [4 ,7 ]
Ostad, Seyed Nasser [1 ,5 ,6 ]
机构
[1] Univ Tehran Med Sci, Dept Pharmacol & Toxicol, Tehran, Iran
[2] Smart Univ Med Sci, Dept Artificial Intelligence, Tehran, Iran
[3] Islamic Azad Univ Med Sci, Sch Pharm, Tehran, Iran
[4] Iran Univ Med Sci, Sch Pharm, Dept Pharmacognosy & Pharmaceut Biotechnol, Tehran, Iran
[5] Univ Tehran Med Sci, Toxicol & Poisoning Res Ctr, Dept Toxicol & Pharmacol, Tehran, Iran
[6] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Tehran, Iran
[7] Iran Univ Med Sci, Sch Pharm, Dept Pharmacognosy & Pharmaceut Biotechnol, Tehran, Iran
关键词
Cancer-associated fibroblast; bladder cancer; cancer stem cell; epithelial-mesenchymal transition; co-culture; TUMOR MICROENVIRONMENT; POOR-PROGNOSIS; CELLS; IDENTIFICATION; ACTIVATION; PROMOTE; SNAIL; EMT;
D O I
10.1080/07357907.2023.2237576
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study comparatively evaluated the possible effects of recurrent and non-recurrent patient-derived Cancer-Associated Fibroblasts (CAFs-R and -NR) on the bladder cancer cell line, EJ138. Both groups of CAFs increased cisplatin resistance and altered cell cycle distribution alongside induced resistance to apoptosis. Later, the scratch assay confirmed the cell migration-inducing effects of CAFs on cells. Nonetheless, only CAFs-R managed to increase sphere-formation and clonogenic levels in EJ138 cells, which were later validated by upregulating pluripotency transcription factors. Besides, CAFs-R also affected the expression levels of some of the EMT markers. Our study suggests that CAFs-R had stronger pro-tumorigenic effects on EJ138 cells.
引用
收藏
页码:656 / 671
页数:16
相关论文
共 47 条
  • [11] CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer
    Hu, J. L.
    Wang, W.
    Lan, X. L.
    Zeng, Z. C.
    Liang, Y. S.
    Yan, Y. R.
    Song, F. Y.
    Wang, F. F.
    Zhu, X. H.
    Liao, W. J.
    Liao, W. T.
    Ding, Y. Q.
    Liang, L.
    MOLECULAR CANCER, 2019, 18 (1)
  • [12] Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene
    Wang, Xiaoyun
    Sun, Xiwen
    Mu, Lin
    Chen, Wei
    CANCER INVESTIGATION, 2019, 37 (03) : 134 - 143
  • [13] Wnt/β-catenin pathway as a link between therapy resistance-driven epithelial-mesenchymal transition and stemness in colorectal cancer
    Rocha, Murilo Ramos
    Castillo-Medina, Yuri Kelly
    Coelho, Barbara Martins de Lima
    Rios, Luidy Lucas Lopes
    Morgado-Diaz, Jose Andres
    CELL BIOLOGY INTERNATIONAL, 2025, 49 (02) : 154 - 160
  • [14] Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer
    Zhu, Xiaoming
    Han, Shuangyin
    Wu, Sen
    Bai, Yangqiu
    Zhang, Ning
    Wei, Li
    EXPERIMENTAL CELL RESEARCH, 2019, 375 (02) : 41 - 50
  • [15] Cancer-associated fibroblasts induce epithelial–mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling
    Cassandra Ringuette Goulet
    Audrey Champagne
    Geneviève Bernard
    Dominique Vandal
    Stéphane Chabaud
    Frédéric Pouliot
    Stéphane Bolduc
    BMC Cancer, 19
  • [16] Patient-Derived Primary Cancer-Associated Fibroblasts Mediate Resistance to Anti-Angiogenic Drug in Ovarian Cancers
    Sulaiman, Raed
    De, Pradip
    Aske, Jennifer C. C.
    Lin, Xiaoqian
    Dale, Adam
    Koirala, Nischal
    Gaster, Kris
    Espaillat, Luis Rojas
    Starks, David
    Dey, Nandini
    BIOMEDICINES, 2023, 11 (01)
  • [17] Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma
    Guinn, Samantha
    Kinny-Koster, Benedict
    Tandurella, Joseph A.
    Mitchell, Jacob T.
    Sidiropoulos, Dimitrios N.
    Loth, Melanie
    Lyman, Melissa R.
    Pucsek, Alexandra B.
    Zabransky, Daniel J.
    Lee, Jae W.
    Kartalia, Emma
    Ramani, Mili
    Seppala, Toni T.
    Cherry, Christopher
    Suri, Reecha
    Zlomke, Haley
    Patel, Jignasha
    He, Jin
    Wolfgang, Christopher L.
    Yu, Jun
    Zheng, Lei
    Ryan, David P.
    Ting, David T.
    Kimmelman, Alec
    Gupta, Anuj
    Danilova, Ludmila
    Elisseeff, Jennifer H.
    Wood, Laura D.
    Stein-O'Brien, Genevieve
    Kagohara, Luciane T.
    Jaffee, Elizabeth M.
    Burkhart, Richard A.
    Fertig, Elana J.
    Zimmerman, Jacquelyn W.
    CANCER RESEARCH, 2024, 84 (09) : 1517 - 1533
  • [18] Tenascin C in pancreatic cancer-associated fibroblasts enhances epithelial mesenchymal transition and is associated with resistance to immune checkpoint inhibitor
    Furuhashi, Satoru
    Morita, Yoshifumi
    Matsumoto, Akio
    Ida, Shinya
    Muraki, Ryuta
    Kitajima, Ryo
    Takeda, Makoto
    Kikuchi, Hirotoshi
    Hiramatsu, Yoshihiro
    Takeuchi, Hiroya
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (11): : 5641 - +
  • [19] Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation
    Izar, Benjamin
    Joyce, Cailin E.
    Goff, Stephanie
    Cho, Nancy L.
    Shah, Parin M.
    Sharma, Gaurav
    Li, Jingjing
    Ibrahim, Nageatte
    Gold, Jason
    Hodi, F. Stephen
    Garraway, Levi A.
    Novina, Carl D.
    Bertagnolli, Monica M.
    Yoon, Charles H.
    PIGMENT CELL & MELANOMA RESEARCH, 2016, 29 (06) : 656 - 668
  • [20] A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial-mesenchymal transition reversion
    Guo, Jian
    Zeng, Huating
    Shi, Xinmeng
    Han, Tao
    Liu, Yimin
    Liu, Yuping
    Liu, Congyan
    Qu, Ding
    Chen, Yan
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)